Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor update to the entry.
    Difference
    0.1%
    Check dated 2026-08-29T20:13:38.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a platform update. This change does not affect the study details or other visible content.
    Difference
    0.1%
    Check dated 2026-08-08T18:23:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This update does not modify the study information or how the page functions.
    Difference
    0.1%
    Check dated 2026-07-25T10:23:51.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision label changed from v3.6.2 to v3.6.3, signaling a system or UI update. No study content, eligibility criteria, or results were altered.
    Difference
    0.1%
    Check dated 2026-07-03T23:27:02.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2, signaling an update to the study record since the prior version.
    Difference
    0.1%
    Check dated 2026-06-26T23:34:52.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The page’s Study Details metadata and labels have been updated to include the investigator’s name and verification status, and to standardize the treatment-related heading.
    Difference
    2%
    Check dated 2026-06-12T16:47:00.000Z thumbnail image

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.